Radiologic Evaluation of Suspected Renovascular Hypertension

被引:0
|
作者
Hartman, Robert P. [1 ]
Kawashima, Akira [1 ]
机构
[1] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
关键词
RENAL-ARTERY STENOSIS; NEPHROGENIC SYSTEMIC FIBROSIS; CAPTOPRIL RENOGRAPHY; ANGIOGRAPHY; DIAGNOSIS;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
More than 72 million Americans have hypertension, and the majority of these persons have essential hypertension. However, a significant subset has a secondary cause. The most common cause of secondary hypertension is renal vascular hypertension, of which renal artery stenosis is the leading pathology. Up to 5 percent of all occurrences of hypertension are caused by renal artery stenosis, equating to as many as 3.5 to 4 million occurrences in the United States. Detecting renal artery stenosis is particularly important for ensuring that this potentially curable form of hypertension is identified and treated properly. Duplex Doppler ultrasonography is a good screening test in many patients, but it has limitations in larger persons and can overlook small accessory arteries. For patients with normal renal function but a high clinical index of suspicion for renovascular disease, contrast-enhanced magnetic resonance angiography and computed tomographic angiography are the most accurate imaging tests. For patients with diminished renal function, gadolinium-enhanced contrast magnetic resonance angiography is the best imaging test. However, caution is warranted because exposure to gadolinium contrast agents is associated with nephrogenic systemic fibrosis in patients with renal failure. The American College of Radiology has developed appropriateness criteria for imaging tests related to the diagnosis of renal artery stenosis. This article is a summary of the recommendations, with the advantages and limitations of each test. (Am Fam Physician. 2009;80(3):273-279. Copyright (C) 2009 American Academy of Family Physicians.)
引用
收藏
页码:273 / 279
页数:7
相关论文
共 50 条
  • [31] Diagnosing renovascular hypertension
    Ahmad, I
    Ray, CE
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2001, 18 (01) : 11 - 21
  • [32] Nonatherosclerotic Renovascular Hypertension
    Dalman, Jessie
    Coleman, Dawn M.
    SURGICAL CLINICS OF NORTH AMERICA, 2023, 103 (04) : 733 - 743
  • [33] Renovascular hypertension in children
    Patel, Premal Amrishkumar
    Cahill, Anne Marie
    CVIR ENDOVASCULAR, 2021, 4 (01)
  • [34] Management of renovascular hypertension
    Textor, Stephen C.
    CURRENT OPINION IN CARDIOLOGY, 2020, 35 (06) : 627 - 635
  • [35] Renovascular hypertension in blacks
    Emovon, OE
    Klotman, PE
    Dunnick, NR
    Kadir, S
    Svetkey, LP
    AMERICAN JOURNAL OF HYPERTENSION, 1996, 9 (01) : 18 - 23
  • [36] Renovascular hypertension in 2007: Where are we now?
    Textor S.C.
    Current Cardiology Reports, 2007, 9 (6) : 453 - 461
  • [37] Pathogenesis and management of renovascular hypertension and ischemic nephropathy
    Yerram, P.
    Karuparthi, P. R.
    Chaudhary, K.
    MINERVA UROLOGICA E NEFROLOGICA, 2012, 64 (01) : 63 - 72
  • [38] Pre- and postcaptopril renal scintigraphy as a screening test for renovascular hypertension in children
    Abdulsamea, Sameh
    Anderson, Peter
    Biassoni, Lorenzo
    Brennan, Eileen
    McLaren, Clare A.
    Marks, Stephen D.
    Roebuck, Derek J.
    Selim, Sabry
    Tullus, Kjell
    PEDIATRIC NEPHROLOGY, 2010, 25 (02) : 317 - 322
  • [39] Renovascular Hypertension To Stent or Not to Stent?
    Mark, Patrick B.
    Schiffrin, Ernesto L.
    Jennings, Garry L.
    Dominiczak, Anna F.
    Wang, Ji-Guang
    De Buyzere, Marc
    Staessen, Jan A.
    HYPERTENSION, 2014, 64 (06) : 1165 - 1168
  • [40] Current Approaches to Renovascular Hypertension
    Textor, Stephen C.
    MEDICAL CLINICS OF NORTH AMERICA, 2009, 93 (03) : 717 - +